Oxazepam and Dissociation - a phase IV clinical study of FDA data

Summary:

Dissociation is reported as a side effect among people who take Oxazepam (oxazepam), especially for people who are male, 60+ old, also take Escitalopram, and have Bipolar ii disorder.

The phase IV clinical study analyzes which people have Dissociation when taking Oxazepam. It is created by eHealthMe based on reports of 23,551 people who have side effects when taking Oxazepam from the FDA, and is updated regularly.

What is Oxazepam?

Oxazepam has active ingredients of oxazepam. It is often used in stress and anxiety. eHealthMe is studying from 23,836 Oxazepam users. Check the latest studies of Oxazepam.

What is Dissociation?

Dissociation is found to be associated with 333 drugs and 536 conditions by eHealthMe. Check the latest studies of Dissociation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

23,551 people reported to have side effects when taking Oxazepam.
Among them, 31 people (0.13%) have Dissociation.

Among these 31 people:

What is the gender of people who have Dissociation when taking Oxazepam? *

female: 41.67 %
male: 58.33 %

What is the age of people who have Dissociation when taking Oxazepam? *

What are other drugs people take besides Oxazepam? *

What are other side effects people have besides Dissociation? *

Suicidal Ideation: 19 people, 61.29%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 17 people, 54.84%
Disturbance In Attention: 17 people, 54.84%
Depressed Mood: 14 people, 45.16%
Bradyphrenia (neurological term referring to the slowness of thought common to many disorders of the brain): 14 people, 45.16%
Fear: 14 people, 45.16%
Drug Ineffective: 14 people, 45.16%
Hypokinesia (decreased bodily movement): 14 people, 45.16%
Thinking Abnormal: 14 people, 45.16%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 14 people, 45.16%

What are the existing conditions these people have? *

Bipolar Ii Disorder (characterized by at least one episode of hypomania and at least one episode of major depression): 5 people, 16.13%
Depression: 3 people, 9.68%
Depressed Mood: 3 people, 9.68%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 9.68%
Psychotic Disorder: 1 person, 3.23%
Pain: 1 person, 3.23%
High Blood Pressure: 1 person, 3.23%
High Blood Cholesterol: 1 person, 3.23%
Gingivitis (inflammation of gums): 1 person, 3.23%
Enlarged Prostate: 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Oxazepam and have Dissociation?

- Check whether Dissociation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Oxazepam:

Oxazepam (23,836 reports)

Dissociation treatments and more:

Dissociation (5,922 reports)

Browse all side effects of Oxazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dissociation:

Dissociation (333 drugs)

Browse all the conditions that are associated with Dissociation:

Dissociation (536 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxazepam (the active ingredients of Oxazepam) and Oxazepam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.